Quick Answer
NOVARTIS AG reported Gross Profit of $42.98 billion for fiscal year 2025.
NOVARTIS AG Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $42.98B | +10.5% |
| 2024 | $38.90B | +13.8% |
| 2023 | $34.19B | +7.2% |
| 2022 | $31.88B | -1.1% |
| 2021 | $32.24B | -7.3% |
| 2020 | $34.78B | +1.5% |
| 2019 | $34.25B | +8.4% |
| 2018 | $31.59B | +6.1% |
| 2017 | $29.77B | -6.7% |
| 2016 | $31.92B | — |
- NOVARTIS AG showed an increase of +10.5% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, NOVARTIS AG’s gross profit has grown by 34.7% (from $31.92 billion to $42.98 billion).
- The most recent figure is from NOVARTIS AG’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: